← All Drugs Made in America Acquisition Ii CORP filings

Drugs Made in America Acquisition Ii CORP Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
DMII
Drugs Made in America Acquisition Ii CORP
Form 4: DMII Director Catherine Do Boosts Stake
Director Catherine Do of Drugs Made In America Acquisition II Corp. acquired 100,000 ordinary shares from the company's sponsor for no consideration.
NASDAQ
DMII
Drugs Made in America Acquisition Ii CORP
Form 4: DMII Director Shulgan Acquires 100,000 Shares
Myron W. Shulgan, a director of Drugs Made In America Acquisition II Corp., acquired 100,000 ordinary shares from the company's sponsor for no consideration.
NASDAQ
DMII
Drugs Made in America Acquisition Ii CORP
Form 4: CFO Glenn Worman Acquires 100,000 DMII Shares
Drugs Made In America Acquisition II Corp. CFO Glenn Worman acquired 100,000 ordinary shares from the company's sponsor for no consideration.
NASDAQ
DMII
Drugs Made in America Acquisition Ii CORP
Form 4: DMII CEO Stockwell Reports Major Share Transactions
Lynn Stockwell, CEO of Drugs Made In America Acquisition II Corp., reported significant indirect share acquisitions and transfers to officers, directors, and accredited investors.
NASDAQ
DMII
Drugs Made in America Acquisition Ii CORP
Form 4: DMII Sponsor Adjusts Holdings, Acquires Units
Drugs Made In America Acquisition II LLC, a 10% owner, reported significant changes in its beneficial ownership of ordinary shares and derivative securities, including an acquisition of private units and transfers to officers, directors, and accredited investors.
NASDAQ
DMII
Drugs Made in America Acquisition Ii CORP
Form 4: Director Acquires 100,000 DMII Shares
Sridhar G. Prasad, a Director and 10% owner of Drugs Made In America Acquisition II Corp., acquired 100,000 ordinary shares from the company's sponsor for no consideration.